Environmental exposures and mutational patterns of cancer genomes
The etiology of most human cancers is unknown. Genetic inheritance and environmental factors are thought to have major roles, and for some types of cancer, exposure to carcinoge...
Publications
Explore 261 academic publications
Showing 12 of
261 publications
Chronic Myelogenous Leukemia, Version 1.2015
Chronic myelogenous leukemia (CML) is usually diagnosed in the chronic phase. Untreated chronic phase CML will eventually progress to advanced phase (accelerated or blast phase)...
Reactivity of Thiols with Superoxide Radicals
Journal Article Reactivity of Thiols with Superoxide Radicals Get access Kozi Asada, Kozi Asada The Research Institute for Food Science, Kyoto University, Uji, Kyoto 611, Japan ...
A New Method of Predicting US and State-Level Cancer Mortality Counts for the Current Calendar Year
Every January for more than 40 years, the American Cancer Society (ACS) has estimated the total number of cancer deaths that are expected to occur in the United States and indiv...
Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer
Proliferation and maintenance of both normal and prostate cancer (PCa) cells is highly regulated by steroid hormones, particularly androgens, and the extracellular environment. ...
SOAP-based services provided by the European Bioinformatics Institute
SOAP (Simple Object Access Protocol) (http://www.w3.org/TR/soap) based Web Services technology (http://www.w3.org/ws) has gained much attention as an open standard enabling inte...
Treatment Effects in Competing-Risks Analysis of Prostate Cancer Data
Green and Byar (1980, Bulletin Cancer, Paris, 67, 477-488) have analysed some data from a randomised clinical trial comparing treatment for patients with prostate cancer in stag...
Long-term OS for patients with advanced NSCLC enrolled in the KEYNOTE-001 study of pembrolizumab (pembro).
9026 Background: The anti–PD-1 antibody pembro (MK-3475) is approved in the US for treating PD-L1–positive NSCLC that progressed after platinum-containing chemotherapy. This app...